Prevalence and outcomes of atrial fibrillation in patients hospitalized with COVID-19-Reference-Cited by-同舟云学术

Prevalence and outcomes of atrial fibrillation in patients hospitalized with COVID-19

Published:2024-07-26 Issue:9 Volume:40 Page:1477-1481
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Vaidean Georgeta D.¹,Rubens Muni¹²³,Ramamoorthy Venkataraghavan⁴,Saxena Anshul¹⁴,Appunni Sandeep⁵,Khosla Atulya Aman⁶,Doke Mayur⁷,Körfer Daniel⁸,Chaparro Sandra¹⁸,Jimenez Javier¹⁸

Affiliation:

1. Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA

2. Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA

3. Department of Health Science, Universidad Espíritu Santo, Samborondón, Ecuador

4. Center for Advanced Analytics, Baptist Health South Florida, Miami, FL, USA

5. Department of Biochemistry, Government Medical College, Kozhikode, Kerala, India

6. Department of Internal Medicine, William Beaumont University Hospital, Royal Oak, MI, USA

7. Diabetes Research Institute, University of Miami, Miami, FL, USA

8. Miami Cardiac & Vascular Institute, Baptist Health South Florida, Miami, FL, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2024.2378179

Reference19 articles.

1. Worldwide Epidemiology of Atrial Fibrillation

2. Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association

3. The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19

4. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

5. New-Onset Atrial Fibrillation in Sepsis: A Narrative Review